medline.ch Respirationstrakt Neoplasie

	Next-Generation Checkpoint Combinations: Optimizing PD-(L)1-Based Therapy Across the Advanced, Adjuvant, and Neoadjuvant Settings. Curr Oncol Rep Petrelli F, Colombo Zefinetti L, D'Alessio A, Dottorini L, Ghidini A. PMID: 42406187 [PubMed - indexed for MEDLINE]
	Preoperative sarcopenia diagnosed based on the asian working group criteria and Short-term outcomes in older patients undergoing resection of early-stage non-small cell lung cancer. Surg Today Toyota M, Oshima Y, Menju T, Yoshioka Y, Hamada R, Asano T, Otagaki A, Niwa Y, Yamaguchi T, Nankaku M, Yamaki H, Tanabe N, Sato S, Tanaka S, Nakajima D, Chen-Yoshikawa TF, Ikeguchi R. PMID: 42406103 [PubMed - as supplied by publisher]
	Factors Influencing Interoception in Patients With Lung Cancer Undergoing Chemotherapy: A Cross-Sectional Study Based on the Common-Sense Model of Self-Regulation. Cancer Nurs Zhang X, Chen X, Wu X, Li J, Wang T, Teng L. PMID: 42405582 [PubMed - as supplied by publisher]
	An IHC-derived TLS-CD8-macrophage immune niche score predicts major pathological response to neoadjuvant chemoimmunotherapy in resectable NSCLC. Front Immunol Tan J, Liu Y, Wang B, Liu H. PMID: 42404907 [PubMed - indexed for MEDLINE]
	Osimertinib Resistance in EGFR-Mutated Non-Small Cell Lung Cancer: Mechanisms and Therapeutic Strategies. MedComm (2020) Guo J, Wen Q, Fan S. PMID: 42404586 [PubMed]
	Circulating miR-107, miR-199, and miR-485 Have High Diagnostic Potential in Non-small Cell Lung Cancer: An Exploratory Study. Clin Med Insights Oncol Serilmez M, Sen S, Ozgur E, Karaman S, Gezer U. PMID: 42403938 [PubMed]
	Modified sini powder for the management of postoperative depression in non-small cell lung cancer patients: a multicenter, randomized, double-blind, placebo-controlled trial protocol. Front Pharmacol Jin Y, Wang J, Li H, Fan M, Zhang S, Lin B, Mi Y, Gong C, Gu P, Xu K, Zhao B, Lang J, Chen M. PMID: 42403716 [PubMed]
	Lung colloid adenocarcinoma: A multidisciplinary diagnostic challenge. Radiol Case Rep Góis Serrano MA, Maia M, Ferreira C, Gomes I. PMID: 42403652 [PubMed]
	Pulmonary tularemia presenting as bilateral pulmonary nodules during BEP chemotherapy for testicular embryonal carcinoma: A diagnostic challenge. Radiol Case Rep Shadmani G. PMID: 42403642 [PubMed]
	Barriers and Facilitators to Lung Cancer Screening in Rural and Academic Medical Center Primary Care Facilities. J Health Care Poor Underserved Lambart LM, Nollen NL, Ellerbeck E, Katz A, Lee SC. PMID: 42403324 [PubMed - indexed for MEDLINE]
	Hoarseness as a Manifestation of Chronic Lymphocytic Leukaemia Involving the Larynx. J Coll Physicians Surg Pak Osmani AH. PMID: 42403145 [PubMed - indexed for MEDLINE]
	Development and external validation of a dual-stage predictive model for self-reported physician-diagnosed chronic lung disease, asthma, and lung cancer in Chinese adults. Sci Rep Cui X, Sun X. PMID: 42401586 [PubMed - as supplied by publisher]
	Efficacy and safety of second-line treatments in ALK mutation-positive advanced non-small cell lung cancer after second- or third-generation ALK inhibitors: Turkish Oncology Group real-life study (TOG study). Clin Transl Oncol Erol C, Zeynelgil E, Hizal M, Dumludag A, Erciyestepe M, Kalaci E, Biter S, Sakalar T, Keskink, Kahraman S, Isik S, Gursoy P, Kutlu Y, Ergun Y, Deliktas I, Yildiz O, Araz M, Akbas S, Can Sanci P, Uygun K, Kalkan Z, Bayram D, Uncu D, Oksuz S, Turan N, Ates O, Bilici A, Kilickap S, Oztop I, Karakaya S, Paydas S, Demirkazik A, Karadurmus N, Sendur MAN. PMID: 42400766 [PubMed - as supplied by publisher]
	A causal association between Epstein-Barr virus infection and lung cancer: A two-sample Mendelian Randomization study. Cancer Biomark Wang J, Wang K, Wang Z. PMID: 42400365 [PubMed - indexed for MEDLINE]
	Liposomal drug delivery for lung cancer therapy: progress, challenges, and future perspectives. Mol Cancer Vatankhah A, Hoseinzadeh Moghaddam S, Rahmanian M, Khosropanah S, Oroojalian F, Kesharwani P, Sahebkar A. PMID: 42400029 [PubMed - as supplied by publisher]
	Prognostic significance of nodal subclassification and adjuvant therapy in surgically treated T1-4N1-2M0 non-small cell lung cancer: a single-center retrospective study. BMC Pulm Med Elma B, Ulu, , I. PMID: 42399895 [PubMed - as supplied by publisher]
	Epidemiological trends of non-small cell lung cancer and systemic treatment rates as part of initial therapeutic strategy from 2016 to 2020 in Greece: results of the epidemiological part of INFINITY study. BMC Cancer Agelaki S, Demiri S, Kotsakis A, Mauri D, Mountzios G, Christopoulou A, Christodoulou C, Goumas G, Bafaloukos D, Koumarianou A, Korantzis I, Boukovinas I, Linardou H, Kosmidis P, Zagouri F, Ramfidis V, Emmanouilides C, Desiniotis A, Dimitriadis I, Iliopoulou E, Syrigos KN. PMID: 42399856 [PubMed - as supplied by publisher]
	Clinical outcomes of immune checkpoint inhibitor based therapy in NRG1 fusion positive non small cell lung cancer a retrospective study. Discov Oncol Yan X, Fu X, Long Z, Liu L, Zang Y, Su C. PMID: 42399487 [PubMed - as supplied by publisher]
	Interventional Radiology and Thoracic Oncology: 20 Years of Innovation. J Thorac Oncol Ryan DT, Shah R, Ridge CA. PMID: 42399004 [PubMed - indexed for MEDLINE]
	Differential impact of proton pump inhibitors and antibiotics on immunotherapy efficacy after chemoradiotherapy in locally advanced non-small-cell lung cancer: a post-hoc analysis of the PACIFIC trial. Lancet Oncol Brunetti L, Santo V, Pinato DJ, Citarella F, Orlando S, Acker F, Colella V, Ricciuti B, Naidoo J, Nassar A, Wakelee HA, Takada K, Naqash AR, Garassino MC, Greco C, Ramella S, Pantano F, Tonini G, Vincenzi B, Arlunno B, Remon J, Parisi C, Planchard D, Besse B, Desilets A, Routy B, Elkrief A, Barlesi F, Derosa L, Cortellini A. PMID: 42398520 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 161234

Seite 1 von 8062



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung